CABA4:01 PMCabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)cabalettabio.com
CABA7:30 AMCabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business UpdatePresentation / Abstract • Phase 1/2EULAR 2026 presentation Mon, Jun 1, 2026cabalettabio.com